Hostname: page-component-586b7cd67f-g8jcs Total loading time: 0 Render date: 2024-11-29T08:37:28.857Z Has data issue: false hasContentIssue false
  • English
  • Français

Sexual Health in Parkinson’s Disease

Published online by Cambridge University Press:  16 April 2020

J. Azevedo ,
M.J. Rosas ,
M. Esteves ,
C. Sousa ,
R. Vaz ,
C. Garrett  and
A. Palha
J. Azevedo
Affiliation:
Psychiatry, HSJ-EPE/FMUP, Oporto, Portugal
M.J. Rosas
Affiliation:
Neurology, HSJ-EPE, Porto, Portugal
M. Esteves
Affiliation:
Psychiatry, HSJ-EPE/FMUP, Oporto, Portugal
C. Sousa
Affiliation:
Neurology, HSJ-EPE, Oporto, Portugal
R. Vaz
Affiliation:
Neurocirurgy, HSJ-EPE/FMUP, Oporto, Portugal
C. Garrett
Affiliation:
Neurology, HSJ-EPE/FMUP, Oporto, Portugal
A. Palha
Affiliation:
Psychiatry, HSJ-EPE/FMUP, Oporto, Portugal

Abstract

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.
Introduction:

The changes in sexual health of patients with Parkinson's disease must be a concern to the clinicians. The effects in sexual health of patients submitted to functional cirurgy is still a matter of debate.

Objectives:

To describe and evaluate the sexual health of patients with Parkinson's disease following deep brain stimulation (DBS) of the subthalamic nucleus (STN).

Methods:

Patients with Parkinson's disease bilaterally implanted for DBS of STN and those only pharmacologically treated, will be evaluated. Sexual functioning will be assessed using the international erectile function indices (IEFI) and the female sexual function indices (FSFI). Depression and anxiety will be evaluated using the Beck depression inventory and the brief symptom indices. Relations between sexual functioning and modifications in the severity of disease (Hoehn and Yahr stage), reduction in levodopa equivalent daily dosage (LEDD), age, and duration of disease will be analyzed.

Results and conlusions:

We expect to find positive changes in the sexual health of these patients, given the fact of the procedure improve the overall burden of the disease by reduction of medication and motor symptoms.

Type
P02-196
Information
European Psychiatry , Volume 24 , Issue S1: 17th EPA Congress - Lisbon, Portugal, January 2009, Abstract book , January 2009 , 24-E886
Copyright
Copyright © European Psychiatric Association 2009
Submit a response

Comments

No Comments have been published for this article.